Dell Upgraded, Tesla Downgraded: Updated Rankings on Top Blue-Chip StocksInvestorPlace·2 days ago, 08:24 AMAXP-0.53%DELL-5.40%
Moderna (MRNA) Stock Looks Above Fair Value After Cancer Trial NewsSimplywall·Jul 24 at 04:14 AMMRNA-2.05%MRNX-4.04%
Earnings Preview: What To Expect From Moderna’s ReportBarchart Option·Jul 23 at 06:48 AMMRNA-2.05%MRNX-4.04%
Moderna (MRNA) Adds Finance Veteran To Its Board, Is The Stock Fully Valued?Simplywall·Jul 22 at 08:14 AMMRNA-2.05%MRNX-4.04%
FairJourney Bio Announces Scientific Program and Leadership for The Antibody Series 2026MorningStar·Jul 21 at 04:04 AMMRNA-2.05%MRNX-4.04%
Arbutus Biopharma Ends RSV Agreement With Genevant; Receives $1 Million Termination FeeTradingView·Jul 16 at 06:33 AMABUS-1.93%MRNA-2.05%
Arbutus files patent infringement suits against Pfizer, BioNTech over LNP technologyPUBT·Jul 16 at 06:32 AMABUS-1.93%MRNA-2.05%
Moderna doses first patient in Phase 1 trial of mRNA-4200 cancer therapy in solid tumorsPUBT·Jul 16 at 06:05 AMMRNA-2.05%MRNX-4.04%
Moderna (MRNA) Stock Looks Stretched On Sales But Reasonable On MomentumSimplywall·Jul 15 at 12:06 PMMRNA-2.05%MRNX-4.04%
